Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,288.00
Bid: 2,284.00
Ask: 2,290.00
Change: -32.00 (-1.38%)
Spread: 6.00 (0.263%)
Open: 2,266.00
High: 2,312.00
Low: 2,258.00
Prev. Close: 2,320.00
DLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ACQUISITION OF BLUE STAR HOUSE, BRIXTON SW9

30 Jan 2020 07:00

RNS Number : 3581B
Derwent London PLC
30 January 2020
 

Derwent London plc ("Derwent London" / "the Group")ACQUISITION OF BLUE STAR HOUSE, BRIXTON SW9

Derwent London is pleased to announce that it has exchanged contracts to acquire the freehold interest in Blue Star House, 234-244 Stockwell Road, Brixton SW9 for £38.1m before costs. The 53,750 sq ft eleven-storey building comprises multi-let office space, including two vacant floors, with restaurant and leisure accommodation at ground/podium level. The rent on acquisition is £0.8m, equating to a low average rent of £14.50 per sq ft on the occupied office space. The acquisition price equates to a capital value of £710 per sq ft.

 

The property, which sits on a 0.7 acre site that includes a surface car park, is located immediately opposite the Brixton O2 Academy. Brixton underground and overground stations are only a few minutes' walk away with travel times to Victoria and Oxford Circus of just 7 and 11 minutes respectively.

 

Vacant possession can be achieved in the next few years and there is scope to redevelop the site with a significantly larger scheme.

 

Paul Williams, Chief Executive at Derwent London, said:

"We are delighted to have acquired Blue Star House and added Brixton as a location within our portfolio. With its excellent connectivity to the West End, we see this as an exciting addition to our substantial development pipeline."

- ends -

 

For further information, please contact:

 

Derwent London

Tel: +44 (0)20 7659 3000

 

Paul Williams, Chief Executive

David Silverman, Director

Quentin Freeman, Head of Investor Relations

 

Brunswick Group

Tel: +44 (0)20 7404 5959

 

 

Nina Coad

Emily Trapnell

 

 

 

 

Notes to editors

 

 

Derwent London plc

Derwent London plc owns 84 buildings in a commercial real estate portfolio predominantly in central London valued at £5.4 billion (including joint ventures) as at 30 June 2019, making it the largest London-focused real estate investment trust (REIT).

 

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via development or refurbishment, effective asset management and capital recycling.

 

We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design.

 

Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

 

As part of our commitment to lead the industry in mitigating climate change, in October 2019, Derwent London became the first UK REIT to sign a Green Revolving Credit Facility. At the same time, we also launched our Green Finance Framework and signed the Better Buildings Partnership's climate change commitment. The Group is a member of the 'RE100' which recognises Derwent London as an influential company, committed to 100% renewable power by purchasing renewable energy, a key step in becoming a net zero carbon business. Derwent London is one of only a few property companies worldwide to have science-based carbon targets validated by the Science Based Targets initiative (SBTi).

 

Landmark schemes in our 5.7 million sq ft portfolio include Brunel Building W2, White Collar Factory EC1, Angel Building EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1.

 

In 2019, the Group has won several awards including EG Offices Company of the Year, the CoStar West End Deal of the Year for Brunel Building, Westminster Business Council's Best Achievement in Sustainability award and topped the real estate sector and was placed ninth overall in the Management Today 2019 awards for 'Britain's Most Admired Companies'. In 2013 the Company launched a voluntary Community Fund and has to date supported 96 community projects in the West End and the Tech Belt.

 

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

 

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon

 

 

Forward-looking statements

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any statements about future outlook involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. Actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements.

No representation or warranty is given in relation to any forward-looking statements made by Derwent London, including as to their completeness or accuracy. Derwent London does not undertake to update any forward-looking statements whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQKKCBNKBKBBDB
Date   Source Headline
22nd Jul 20143:00 pmRNSDisposal
15th Jul 20145:35 pmRNSNotice of Results
11th Jul 20147:45 amRNSSuccessful Pre-Let to Freud Communications
1st Jul 20145:45 pmRNSTotal Voting Rights
11th Jun 201410:30 amRNSAdditional Listing
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:00 pmRNSDirector/PDMR Shareholding
2nd Jun 20145:25 pmRNSTotal Voting Rights
30th May 20144:10 pmRNSResolutions of the 2014 Annual General Meeting
21st May 201411:00 amRNSBlocklisting Interim Review
16th May 20145:15 pmRNSResult of AGM
16th May 20143:00 pmRNSBondholders meeting
14th May 20144:55 pmRNSScrip Dividend Scheme
14th May 201412:30 pmRNSHolding(s) in Company
8th May 20147:00 amRNSInterim Management Statement
1st May 20144:00 pmRNSTotal Voting Rights
17th Apr 20149:00 amRNSDocuments available at NSM
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
14th Apr 20144:30 pmRNSDirector/PDMR Shareholding
4th Apr 20144:24 pmRNSDirector/PDMR Shareholding
4th Apr 20144:23 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
4th Apr 20144:20 pmRNSDirector/PDMR Shareholding
2nd Apr 20149:29 amRNSTotal Voting Rights
28th Mar 201410:30 amRNSBlocklisting Interim Review
24th Mar 20147:00 amRNSSale of Jaeger House, 57 Broadwick Street W1
20th Mar 20142:00 pmRNSChange of auditor
19th Mar 20143:55 pmRNSHolding(s) in Company
17th Mar 201410:00 amRNSAdditional Listing
13th Mar 201410:00 amRNSHolding(s) in Company
27th Feb 20147:00 amRNSFinal Results
22nd Jan 20143:00 pmRNSHolding(s) in Company
22nd Jan 20141:15 pmRNSNotice of Results
9th Jan 20149:00 amRNSCompletion of £100m Private Placement
8th Jan 20142:45 pmRNSDirectorate Change
7th Jan 20149:00 amRNSDerwent London acquisition of 22 Kingsway WC2
20th Dec 20133:40 pmRNSHolding(s) in Company
16th Dec 20133:09 pmRNSHolding(s) in Company
6th Dec 20133:00 pmRNSHolding(s) in Company
27th Nov 20135:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.